Basel, 03 September 2018 Reminder: Invitation to Roche’s Virtual Late Stage Pipeline Event 2018 We are pleased to invite investors and analysts to participate in a live video webcast and conference call on Thursday, 13 September 2018, highlighting development and commercial opportunities within our late stage portfolio. The Roche Virtual Late Stage Pipeline Event... Read more
Basel, 30 August 2018 Positive phase III results for Roche’s Hemlibra for haemophilia A without factor VIII inhibitors published in New England Journal of Medicine Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis Hemlibra is the first medicine to demonstrate superior efficacy to prior factor VIII prophylaxis based on a statistically significant reduction in... Read more
Basel, 30 August 2018 Positive phase III results for Roche’s Hemlibra for haemophilia A without factor VIII inhibitors published in New England Journal of Medicine Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis Hemlibra is the first medicine to demonstrate superior efficacy to prior factor VIII prophylaxis based on a statistically significant reduction in... Read more
Basel, 28 August 2018 Changes to the Roche Corporate Executive Committee Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to pursue his career outside of the company effective 30 September 2018. Until a successor is named, Michael Heuer,... Read more
Dundee, UK – 22nd August 2018: Ubiquigent Limited, a company specializing in providing ubiquitin cell-signalling system drug discovery services, research tools and novel targeted chemistry, announced today that it has launched REDOXprofiler™. The new service, validated following a collaboration with Medivir AB, enables the rapid identification of REDOX cycling compounds (RCCs), which may generate false... Read more
August 20, 2018 HORIBA New Jersey Optical Spectroscopy Center to Open HORIBA, Ltd. (Head Office: Kyoto, Japan; hereinafter, “HORIBA”) announced today the relocation of its development and production center for optical analysis and measurement instruments. The relocation will take place within the U.S. state of New Jersey, moving from Edison to Piscataway, with the Center... Read more
August 20, 2018 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, renamed its flagship workflow solution today. Freeslate is now the Big Kahuna. “We really love this product and it deserved to be a part of the Unchained Labs family,” said Taegen Clary, VP... Read more
Basel, 20 August 2018 China National Drug Administration grants rapid approval of Roche’s Alecensa (alectinib) as a treatment for ALK-positive lung cancer Approval follows priority review of Alecensa in China, just eight and nine months after EMA and FDA approvals, respectively Supporting data showed Alecensa significantly reduced the risk of disease progression or death by... Read more
AuthorBy B0ydR0nRSBPosted onAugust 17, 2018 Following the successful introduction of the AQS3TMpro, a protein characterization platform that allows users to ‘See Change in the secondary structure of proteins, the company is directing its focus to application development. Valerie Ivancic has joined the team as an Applications Scientist. She brings experience in the biophysical characterization of amyloid... Read more
Dundee, UK, 15th August 2018: Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system targeted drug discovery, announced today that it was awarded a new grant from Innovate UK as part of its Investor Accelerator Pilot to support a project entitled; ‘The development of novel compounds to seed a neurodegeneration drug discovery programme’.... Read more